GlassScriptPhysician profile
Devanshu V Kansara
NPI 1316940109
$4,232.59
in general payments reported to CMS, 2019-2025
12 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $25.46 · 2021: $19.70 · 2022: $141 · 2023: $574 · 2024: $1,766 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,341 · Travel and Lodging: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,340.84 |
| Travel and Lodging | $374.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,404.62 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Triathlon |
| Depuy Synthes Sales INC. | $964.57 | 2019-2025 | Healix Knotless Peek, Rigidloop, Milagro |
| Smith+Nephew, INC. | $270.22 | 2024 | Real Intelligence, Journey II, Aetos Shoulder System |
| Orthalign INC | $169.06 | 2024-2025 | Orthalign Plus |
| Restor3d, INC. | $123.39 | 2024 | |
| Exactech, INC. | $117.88 | 2019 | |
| Elevate Surgical Co | $61.30 | 2022-2025 | |
| Omnilife Science, INC | $33.31 | 2025 | |
| Boston Scientific Corporation | $26.58 | 2022 | |
| Si-Bone, INC. | $22.26 | 2022 | |
| Trilliant Surgical LLC. | $21.06 | 2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate |
| Vericel Corporation | $18.34 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devanshu Kansara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.